The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Systematic recovery of building plumbing-associated microbial communities after extended periods of altered water demand during the COVID-19 pandemic

    1. Solize Vosloo
    2. Linxuan Huo
    3. Umang Chauhan
    4. Irmarie Cotto
    5. Benjamin Gincley
    6. Katherine J Vilardi
    7. Byungman Yoon
    8. Kelsey J Pieper
    9. Aron Stubbins
    10. Ameet Pinto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study

    1. Naïm Ouldali
    2. Haleh Bagheri
    3. Francesco Salvo
    4. Denise Antona
    5. Antoine Pariente
    6. Claire Leblanc
    7. Martine Tebacher
    8. Joëlle Micallef
    9. Corinne Levy
    10. Robert Cohen
    11. Etienne Javouhey
    12. Brigitte Bader-Meunier
    13. Caroline Ovaert
    14. Sylvain Renolleau
    15. Veronique Hentgen
    16. Isabelle Kone-Paut
    17. Nina Deschamps
    18. Loïc De Pontual
    19. Xavier Iriart
    20. Christelle Gras-Le Guen
    21. François Angoulvant
    22. Alexandre Belot
    23. the “French Covid-19 Paediatric Inflammation Consortium”
    24. the “French Pharmacovigilance network”

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

    1. Devendra K. Rai
    2. Irina Yurgelonis
    3. Patricia McMonagle
    4. Hussin A. Rothan
    5. Li Hao
    6. Alexey Gribenko
    7. Elizabeth Titova
    8. Barry Kreiswirth
    9. Kris M. White
    10. Yuao Zhu
    11. Annaliesa S. Anderson
    12. Rhonda D. Cardin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Noncommunicable diseases risk factors and the risk of COVID-19 among university employees in Indonesia

    1. Indah Suci Widyahening
    2. Dhanasari Vidiawati
    3. Trevino A. Pakasi
    4. Pradana Soewondo
    5. Abdillah Ahsan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

    1. Samantha E. Greasley
    2. Stephen Noell
    3. Olga Plotnikova
    4. RoseAnn Ferre
    5. Wei Liu
    6. Ben Bolanos
    7. Kimberly Fennell
    8. Jennifer Nicki
    9. Tim Craig
    10. Yuao Zhu
    11. Al E. Stewart
    12. Claire M. Steppan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

    1. Maik Pietzner
    2. Robert Lorenz Chua
    3. Eleanor Wheeler
    4. Katharina Jechow
    5. Julian D. S. Willett
    6. Helena Radbruch
    7. Saskia Trump
    8. Bettina Heidecker
    9. Hugo Zeberg
    10. Frank L. Heppner
    11. Roland Eils
    12. Marcus A. Mall
    13. J. Brent Richards
    14. Leif-Erik Sander
    15. Irina Lehmann
    16. Sören Lukassen
    17. Nicholas J. Wareham
    18. Christian Conrad
    19. Claudia Langenberg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence

    1. Nir Gavish
    2. Rami Yaari
    3. Amit Huppert
    4. Guy Katriel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery

    1. Justin J. Frere
    2. Randal A. Serafini
    3. Kerri D. Pryce
    4. Marianna Zazhytska
    5. Kohei Oishi
    6. Ilona Golynker
    7. Maryline Panis
    8. Jeffrey Zimering
    9. Shu Horiuchi
    10. Daisy A. Hoagland
    11. Rasmus Møller
    12. Anne Ruiz
    13. Albana Kodra
    14. Jonathan B. Overdevest
    15. Peter D. Canoll
    16. Alain C. Borczuk
    17. Vasuretha Chandar
    18. Yaron Bram
    19. Robert Schwartz
    20. Stavros Lomvardas
    21. Venetia Zachariou
    22. Benjamin R. tenOever

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity

  9. COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron

    1. Nungruthai Suntronwong
    2. Ritthideach Yorsaeng
    3. Jiratchaya Puenpa
    4. Chompoonut Auphimai
    5. Thanunrat Thongmee
    6. Preeyaporn Vichaiwattana
    7. Sitthichai Kanokudom
    8. Thaneeya Duangchinda
    9. Warangkana Chantima
    10. Pattarakul Pakchotanon
    11. Suvichada Assawakosri
    12. Pornjarim Nilyanimit
    13. Sirapa Klinfueng
    14. Lakkhana Wongsrisang
    15. Donchida Srimuan
    16. Thaksaporn Thatsanatorn
    17. Natthinee Sudhinaraset
    18. Nasamon Wanlapakorn
    19. Yong Poovorawan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Understanding evolution of COVID-19 driven mortality rate

    1. Ishika Bhaumik
    2. Suman Sinha-Ray
    3. Anshul Chaudhary
    4. Abhishek Srivastava
    5. Prashant Kodgire

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 688 of 2361 Older